Percutaneous Coronary Intervention Market is predicted to reach USD 20.53 Billion at a CAGR of 8.86% during the forecast period 2023-2032

Market Research Future (MRFR) has published on the “Global Percutaneous Coronary Intervention Market”.

The Percutaneous Coronary Intervention market is estimated to register a CAGR of 8.86% during the forecast period of 2023 to 2032.

MRFR recognizes the following companies as the key players in the Global Percutaneous Coronary Intervention Market— Boston Scientific Corporation (US), Abbott (US), MicroPort Scientific Corporation (China), Terumo Corporation (Japan), Medtronic (Ireland), Cook (US), APT Medical Inc (China), Merit Medical System (US), Becton, Dickinson, and Company (US), B. Braun SE (Germany), Cardinal Health (US), Meril Life Sciences Pvt. Ltd (India), PLS Minimally Invasive International Medical Co Ltd (China), and Lepu Medical Technology Co., Ltd (China).

Analyst Comment –

“The percutaneous coronary intervention market is experiencing notable growth, propelled by a surge in cardiovascular diseases, advancements in interventional cardiology techniques, and a growing preference for minimally invasive procedures. This market’s trajectory is characterized by innovation, improved patient outcomes, and an expanding aging population, making it pivotal contributor to the dynamic landscape of cardiovascular interventions.”   

Market Highlights

The global percutaneous coronary intervention market is expected to register a CAGR of 8.86% during the forecast period and is estimated to reach USD 20.53 Billion by 2032.

The expected growth in the market can be attributed to the rising prevalence of heart diseases and increasing preference for minimally invasive procedures. However, the market is also held back by the risk of infection and complications during cardiac catheterization. Nevertheless, it is anticipated that the growing technological advancements will create lucrative opportunities for the players operating in the percutaneous coronary intervention market.

Segment Analysis

The global percutaneous coronary intervention market has been segmented based on product type, vascular access, and end user.

On the basis of product type, the market is segmented into coronary stents, ballon catheters, coronary guidewires, guiding catheters, guiding sheaths, diagnostic catheters, crossing catheters, inflation device, guidance system, peripheral thrombectomy system, embolic protection system, and accessories. The coronary stents segment held the majority share in the market in 2022. Moreover, the launch of the newest generation of drug-eluting catheter stents to fulfill the demand of physicians is fueling the growth of the product type segment.

On the basis of vascular access, the market is segmented into radial and femoral. The radial segment dominated the market in 2022. Radial PCI is a safe and effective procedure that can be used to treat a variety of coronary artery diseases. It is the preferred approach to PCI for most patients because it offers several advantages over femoral PCI. Moreover, radial PCI is becoming increasingly popular due to advantages such as reducing the risk of stroke during the procedure and shortening the duration of the hospital stay.

On the basis of end user, the market is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment dominated the market in 2022. This is due to factors such as the increasing number of angioplasties, rising incidences of diabetes & obesity patients may lead to coronary artery diseases.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Percutaneous Coronary Intervention Market Research Report

Regional Analysis

The global percutaneous coronary intervention market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Percutaneous Coronary Intervention market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The percutaneous coronary intervention market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World percutaneous coronary intervention market comprises of Middle East, Africa, and Latin America.

North America held the largest market share due to the increase in demand for minimally invasive procedures, increasing prevalence of cardiovascular diseases, and unhealthy lifestyle habits propelling regional market growth over the forecast period. For instance, In the United States, heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups. Cardiovascular disease claims one life every 33 seconds in the US. In 2021, approximately 695,000 people in the United States died from heart disease, accounting for one in every five deaths.

Europe is further divided into the Germany, France, UK, Italy, Spain, Poland, Netherlands, Belgium, Switzerland, and Rest of Western Europe. Europe accounts for the second-largest market share due to the unhealthy lifestyle habits, increasing geriatric population, and extensive R&D activities. For instance, according to Eurostat more than one-fifth (21.1%) of the EU population would be 65 or older in 2022.

Furthermore, Asia-Pacific is further divided into the India, Japan, Australia, South Korea, Singapore, Vietnam, Thailand, and Rest of Asia-Pacific. The Asia-Pacific market is anticipated to register the fastest growth rate over the forecast period. This is due to factors such as rising income levels, an increase in the prevalence of cardiovascular diseases, and better healthcare infrastructure also drive market growth.

Moreover, the Rest of the World is segmented Middle East, Africa, and Latin America. Factors such as limited healthcare infrastructure, a lack of awareness regarding procedures, and a lack of skilled professionals are restricting the growth of the percutaneous coronary intervention market in the region. Additionally, low healthcare expenditure and unstable political situations are also affecting market growth to some extent. These factors are anticipated to fuel the growth of the percutaneous coronary intervention market in the region.

Key Findings of the Study

• The global percutaneous coronary intervention market is expected to reach USD 20.53 Billion by 2032, at a CAGR of 8.86% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market.


• Based on vascular access, the radial segment was attributed to holding the largest market in 2022.


• Boston Scientific Corporation (US), Abbott (US), MicroPort Scientific Corporation (China), Terumo Corporation (Japan), and Medtronic (Ireland) are the key market players.